It’s early February in Tchaourou district, Borgou in Benin, and a pregnant woman is admitted to hospital. Her premature baby is born by caesarean section but she dies a day later on February 12th. It turns out she had Lassa fever, a deadly viral haemorrhagic disease. But that’s only discovered after the baby is discharged from hospital and taken to northern Togo. The newborn also becomes ill and is taken to hospital for treatment….
Read Tatum Anderson’s April 2017 article in Intellectual Property Watch on the Public-Private Coalition’s High-Profile Delinkage Policy For Emerging Vaccines – Intellectual Property Watch Tatum Anderson April 2017.
Complete your details and we’ll send you regular updates via our newsletter.
Need to understand some element of the biopharma industry or looking for a particular template?